CLINICAL_TRIALS ClinicalTrials.gov record update

Randomized Comparative Clinical Study of the Dietary Supplement "Gepaktiv" (International Name: Phenomenon) in Comparison With Ursodeoxycholic Acid (UDCA) and Ademetionine in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) and Hepatomegaly

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT07068191
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:33.953896+00:00
Published At: 2025-07-23T00:00:00+00:00
Record Updated At: 2025-07-23
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)", "Hepatomegaly", "Nonalcoholic Fatty Liver (NAFL)", "Nonalcoholic Fatty Liver Disease (NAFLD)", "Fatty Liver", "Fatty Liver, Alcoholic", "Fatty Liver, Nonalcoholic", "Fatty Liver Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-07-23"
protocolSection.identificationModule.nctId: "NCT07068191"
protocolSection.identificationModule.officialTitle: "Randomized Comparative Clinical Study of the Dietary Supplement \"Gepaktiv\" (International Name: Phenomenon) in Comparison With Ursodeoxycholic Acid (UDCA) and Ademetionine in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) and Hepatomegaly"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.